Phase II study of gemcitabine, cisplatin, folinic acid (FA) and infusional 5-fluorouracil (5-FU) in patients with inoperable esophageal cancer (IEC)

4238 Background: Our previous phase I study has shown that combination chemotherapy with gemcitabine, 5-FU/FA, and cisplatin (GFFC) is feasible and has encouraging activity in IEC. Therefore, we in...